Pharma Industry Power Players join ACMA Board
The ACMA is excited to announce that it has restructured its Board of Governors to include heavy hitters from the pharmaceutical and life sciences industry.
Among the power players are:
Founder, Managing General Partner JALAA Equities
Board Member, Ligand Pharmaceuticals
Chairman, V ClinBio
Board of Directors, Neurotez Inc.
Board of Directors, Hyalo Technologies
Former President, CEO Otsuka Pharmaceuticals
Sotirios Stergiopoulos, MD, BCMAS
Chief Medical Officer, Head of Global Medical Affairs Ipsen Biosciences
Sharad (Bob) Chib
Head, Corporate Strategy, Innovation & Business Development
Michael Davidson, MD
Founder, Chief Scientific Officer
Professor of Medicine
Prtizker School of Medicine
University of Chicago
William Soliman, PhD, BCMAS
Accreditation Council for Medical Affairs
Additionally, the ACMA is excited to announce that we now have registrants in over 50 countries enrolled in the Board Certified Medical Affairs Specialist (BCMAS) program. ACMA is proud to partner with the Council for Continuing Pharmaceutical Education in Canada, the Indian Pharmaceutical Association, Interfarma in South America and SBMF in Brazil. Together we can help to improve the standard of education & training in the industry and subsequently improve patient outcomes.